Navigation Links
New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease
Date:7/16/2014

's current beliefs; however, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date or that florbetapir F 18 will be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

[1] Petrovitch H, White LR, Ross GW, et al. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology. 2001;57(2):226–234.
[2] Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc. 1999;47(5):564–569.
[3] Grundman M, Pontecorvo MJ, Salloway SP, et al. Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Alzheimer Dis Assoc Disord. 2013 Jan;27(1):4-15.
[4] Alzheimer's Association. 2014 Alzheimer's Disease Facts and Figures. http://www.alz.org/downloads/facts_figures_2014.pdf. Accessed on June 4, 2014.
[5] Alzheimer's Disease International. Policy Brief for Heads of Government: The Global Impact of Dementia 2013 - 2050. http://www.alz.co.uk/research/GlobalImpactDementia2013.pdf. Published December 2013. Accessed on June 4, 2014.
[6] Amyvid [package insert]. Indianapolis, IN: Lilly USA, LLC; 2012. 

Refer to: Stefanie Prodouz, +1 (317) 224-5331,

SOURCE Eli Lilly and Company
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Adynxx Initiates Phase 2 Dose-Ranging Study of AYX1, Lead Compound for the Prevention of Post-Surgical Pain
2. Newly-Published Study Confirms Stretta to be Valuable GERD Treatment
3. New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities
4. Veran Medical Publishes Lung Cancer Patient Management Study
5. Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome
6. Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness
7. Etirinotecan Pegol (NKTR-102) Passes Interim Efficacy Analysis for BEACON Pivotal Phase 3 Clinical Study in Patients with Metastatic Breast Cancer
8. First Subjects Dosed in Phase 1 Clinical Study of NKTR-171, A New Peripherally-Restricted Sodium Channel Blocker to Treat Neuropathic Pain
9. Debiopharm Group Announces Completion of Recruitment for Phase III Clinical Study with Triptorelin 22.5 mg in Central Precocious Puberty
10. Neurocrine Announces 12-Week Safety Results From Initial Phase IIB Study Of VMAT2 Inhibitor NBI-98854
11. EndoChoice Announces Investigator-Initiated Study Program for Fuse Endoscopy System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 28, 2015 CTI BioPharma ... plans to report its second quarter 2015 financial results ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... to the event can be obtained as follows: ...
(Date:7/27/2015)... PARIS , July 28, 2015   ... entered into a new global collaboration to discover, develop ... field of immuno-oncology. As part of the agreement, the ... protein 1 (PD-1) inhibitor currently in Phase 1 testing ... new therapeutic candidates based on ongoing, innovative preclinical programs. ...
(Date:7/27/2015)... WESTLAKE VILLAGE, Calif. , July 27, ... and KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH ) today ... granted early termination of the waiting period under the ... respect to Allergan,s pending acquisition of KYTHERA.  ... July 6, 2015, each of Allergan and KYTHERA filed ...
Breaking Medicine Technology:CTI BioPharma to Report Second Quarter 2015 Financial Results on August 6, 2015 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 2Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 3Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 4Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 5Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 6Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 7Regeneron and Sanofi Launch Major New Immuno-Oncology Collaboration 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9
(Date:7/27/2015)... ... July 28, 2015 , ... Almost a year ago, the US ... counseling for persons who are obese and those who are overweight with at least ... mandate will affect any commercial health plan with a program year start after August ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular risk factors, ... brain volumes that may be early indicators of Alzheimer’s disease and dementia, according ... that vascular risk factors damage the brain and can result in cognitive impairment,” ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National ... a 2015 Professional Woman of the Year. Ms. Baum-Lappe is recognized with this ... professional women in the country, spanning virtually every industry and profession, the National ...
(Date:7/27/2015)... ... July 27, 2015 , ... The FSH Society ... incurable disease, facioscapulohumeral muscular dystrophy (FSHD), today announced the introduction of the first-ever ... care guideline is published today. , This new guideline condenses the results ...
(Date:7/27/2015)... ... July 27, 2015 , ... Eugene Batelli, D.P.M., F.A.C.F.A.S, just recently ... “The patient is high-end athlete, whose accomplishments include running in 27 triathlons and swimming ... pain, which was diagnosed as tendinitis. I did an ultrasound and found a ...
Breaking Medicine News(10 mins):Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3Health News:NAPW Inducts Gilda Baum-Lappe, Journalist / Correspondent of Hollywood Foreign Press Association Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 2Health News:NJ Top Docs Presents, Dr. Eugene Batelli of Metropolitan Ankle & Foot Care Specialists 3
... AMDL, Inc. (NYSE Alternext US: ADL) , a ... its Chairman and CEO Mr. Douglas MacLellan has appeared ... 4, 2009 at 6:40 a.m. ET (3:40 a.m. PT). ... Fox Business News to discuss the Chinese business environment ...
... to Advance Understanding and Treatment of Pulmonary Fibrosis ... for Pulmonary Fibrosis (CPF) and the American Thoracic ... pulmonary, critical care and sleep physicians, today announced ... University Medical Center (Columbus, OH) and Harikrishna ...
... to share their heart-healthy lifestyle choicesDALLAS, Feb. 4 ... while others are life changing. Heart disease is the ... research shows that eighty percent of cardiac events in ... choices for their hearts, involving diet, exercise and abstinence ...
... Invisicare to ChinaLAS VEGAS and PLAINSBORO, N.J., Feb. 4 ... the developers of Invisicare , a ... for topical products, and RHEI Pharmaceuticals NV, a Belgium ... China, today announced they have signed a first option ...
... (Nasdaq: CADX ), a biopharmaceutical company focused ... for use in the hospital setting, announced today that ... the company,s corporate overview on Tuesday, February 10, 2009 ... BIO CEO and Investor Conference at the Waldorf Astoria ...
... Several big names in professional football and television ... 28 for the Third Annual National Walk for Epilepsy. ... Alan Faneca, and Atlanta Falcons running back Jason Snelling, ... their own teams of friends, relatives and fans. Together ...
Cached Medicine News:Health News:AMDL Inc.'s Chairman & CEO Mr. Douglas MacLellan Featured on FOX Business News Wednesday, February 4, 2009 2Health News:AMDL Inc.'s Chairman & CEO Mr. Douglas MacLellan Featured on FOX Business News Wednesday, February 4, 2009 3Health News:Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards 2Health News:Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards 3Health News:Coalition for Pulmonary Fibrosis and American Thoracic Society Announce Recipients of 2009-10 Research Awards 4Health News:Go Red For Women(R) Hosts Casting Call to Beat No. 1 Killer of Women With Celebrity Supporter Andie MacDowell 2Health News:Go Red For Women(R) Hosts Casting Call to Beat No. 1 Killer of Women With Celebrity Supporter Andie MacDowell 3Health News:Go Red For Women(R) Hosts Casting Call to Beat No. 1 Killer of Women With Celebrity Supporter Andie MacDowell 4Health News:Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals 2Health News:Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals 3Health News:Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals 4Health News:Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C. 2Health News:Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C. 3
... The Transfusion Safety Management system ensures your ... and care. , BloodTrack SafeTx uses the ... patient from sample collection to transfusion. SafeTx ... and reduces the need for bedside paperwork ...
... wCareCollect™ improves the specimen collection process. A ... information on the handheld at the bedside. ... the specific patient. Collection status information can ... which can reduce redraws, enhancing patient comfort, ...
... System is a custom-designed nursing ... safety while improving overall efficiency. ... managing a myriad of tasks ... linked real-time to the hospitals ...
Med Administration Check closes the loop on the medication use process by automatically validating and documenting medication administration....
Medicine Products: